Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury
2025 · Diabetology & Metabolic Syndrome · 3 citations
https://doi.org/10.1186/s13098-025-01804-7